Host Defense Peptide LL-37 Selectively Reduces Proinflammatory Macrophage Responses
Kelly L. Brown(University of British Columbia), Pauline Johnson(University of British Columbia), Cláes Dahlgren(Centre for Inflammation Research), Anna Karlsson(Chalmers University of Technology), Robert E. W. Hancock(University of British Columbia), Darlene Birkenhead(University of British Columbia), Reza Falsafi(University of British Columbia), Olga M. Pena(University of British Columbia), Grace F. T. Poon(University of British Columbia), Johan Bylund(Clinical Research Consultants (United States))
Cited by 163
Related Papers
Cationic peptides: a new source of antibiotics
|Trends in biotechnology|1998|1.3k
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index
|Journal of Biological Chemistry|2005|598
Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37
|The Journal of Immunology|2006|556